Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
62 participants
INTERVENTIONAL
2024-03-01
2025-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pectoral Nerve Block During Mastectomy
NCT05699902
Affecting Factors for Chronic Pain After Mastectomy
NCT06592053
Radiofrequency for Chronic Post-mastectomy Pain: is it Better to Target Intercostal Nerves or Corresponding Dorsal Root Ganglia?
NCT03374423
Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Mastectomy:
NCT06082206
Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries
NCT04238377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mirtazapine group
patients will receive orally the night before surgery the study medication and daily up to two weeks after: Mirtazapine group: Mirtazapine 30 mg tablet
Mirtazapine 30 MG
patients will receive orally the night before surgery the study medication and daily up to two weeks after Mirtazapine 30 mg tablet
placebo group
patients will receive orally the night before surgery the study medication and daily up to two weeks after:
placebo tablet
Placebo
patients will receive orally the night before surgery the study medication and daily up to two weeks after placebo tablet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mirtazapine 30 MG
patients will receive orally the night before surgery the study medication and daily up to two weeks after Mirtazapine 30 mg tablet
Placebo
patients will receive orally the night before surgery the study medication and daily up to two weeks after placebo tablet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Rabiee Ali
assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
south Egypt Cancer Institute Assiut University
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mirtazapine for post mastectoy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.